Singapore Markets close in 1 hr 28 mins

Lyell Immunopharma, Inc. (LYEL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.1100+0.2300 (+5.93%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
No. of analysts2333
Avg. Estimate-0.3-0.31-1.21-1.54
Low estimate-0.33-0.36-1.48-2
High estimate-0.28-0.27-0.89-1.08
Year ago EPSN/A-1.47-1.57-1.21
Revenue estimateCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
No. of analysts2344
Avg. EstimateN/A1.07M21.35M24.41M
Low estimateN/AN/AN/AN/A
High estimate1M3.2M64M67M
Year ago salesN/A2.63M10.65M21.35M
Sales growth (year/est)N/A-59.30%100.50%14.30%
Earnings historyInvalid Date29/06/202129/09/202130/12/2021
Est. EPSN/A-0.36-0.27-0.27
Actual EPSN/A-1.47-0.2-0.35
DifferenceN/A-1.110.07-0.08
Surprise %N/A-308.30%25.90%-29.60%
EPS trendCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
Current estimate-0.3-0.31-1.21-1.54
7 days ago-0.29-0.31-1.19-1.54
30 days ago-0.29-0.31-1.19-1.54
60 days ago-0.3-0.31-1.32-1.4
90 days ago-0.3-0.31-1.32-1.4
EPS revisionsCurrent qtr. (Mar 2022)Next qtr. (Jun 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/A1N/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/A1N/A
Growth estimatesLYELIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.78.90%N/AN/AN/A
Current year22.90%N/AN/AN/A
Next year-27.30%N/AN/AN/A
Next 5 years (per annum)-7.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A